FDA Rare Disease Guidelines 2026 | Frank Li at KIC
Dr. Frank Li of BLA Regulatory will speak at 2026 KIC in Seoul on October 15, sharing recent FDA reg...
U.S. Regulatory Strategies for Biotech Companies 2026 | Online
Dr. Frank Li of BLA Regulatory will be a featured speaker at an online seminar hosted by R&D Support...
Meet BLA Regulatory at Medtec Japan & BIO KOREA 2026
BLA Regulatory announces CEO participation at Medtec Japan 2026 and BIO KOREA 2026. Connect with us ...
Dr. Li to Attend BioJapan 2025 — Let’s Connect!
Submitting an IND application to the US FDA is a significant step in the development of a new drug o...
BLA joins in iPark-KBIC Meetup at BIO Boston
Submitting an IND application to the US FDA is a significant step in the development of a new drug o...
Meet BLA at BIO International Convention 2025
Submitting an IND application to the US FDA is a significant step in the development of a new drug o...
Bioeconomy Hub Japan 2025 – Strengthening Global Collaboration in Bioeconomy
Submitting an IND application to the US FDA is a significant step in the development of a new drug o...
US FDA IND Application Strategy & Execution
Submitting an IND application to the US FDA is a significant step in the development of a new drug o...